TUESDAY, Nov. 14, 2023 (HealthDay News) — Children stricken with influenza aren’t receiving the flu-busting antiviral drug Tamiflu even though it’s recommended for them, a new study says. Three of five children with the flu aren’t prescribed Tamiflu, researchers report online Nov. 13 in the journal Pediatrics. “We found thatContinue Reading

THURSDAY, Nov. 9, 2023 (HealthDay News) — Health care workers at America’s nursing homes are woefully under-vaccinated for both flu and COVID-19, threatening their own health and that of the frail elderly patients under their care, a new report finds. Looking at 2023 data collected at nearly 14,000 nursing homesContinue Reading

THURSDAY, Nov. 9, 2023 (HealthDay News) — The best way to prevent cervical cancer in women is to give HPV vaccines to both boys and girls, a new study argues. That way, herd immunity could help eradicate the cancer-causing virus, researchers say. Cancer-related HPV strains declined significantly in Finnish townsContinue Reading

WEDNESDAY, Nov. 1, 2023 (HealthDay News) — Many antibiotics long used to treat common childhood infections are no longer effective because of antibiotic resistance. The authors of a new study say global guidelines on antibiotic use need to be updated to reflect this, and they called for an increased focusContinue Reading

MONDAY, Oct. 30, 2023 (HealthDay News) — A cheap, do-it-yourself air purifier is powerful enough to effectively protect a home from free-floating flu and COVID-19 viruses, according to test results from the U.S. Environmental Protection Agency. The filter, crafted with common hardware store supplies costing $60, outperformed pricey off-the-shelf airContinue Reading

THURSDAY, Oct. 26, 2023 (HealthDay News) – High-risk men should still get their mpox vaccinations even after the ongoing outbreak ends, advisors to the U.S. Centers for Disease Control and Prevention recommended Wednesday.  That vulnerable group includes men who have sex with men; people who have more than one sexualContinue Reading

TUESDAY, Oct. 24, 2023 (HealthDay News) — Demand for a new shot that protects babies against respiratory syncytial virus (RSV) has outpaced supply, prompting U.S. health officials to recommend the doses be saved for high-risk infants. In an alert posted Monday afternoon, the U.S. Centers for Disease Control and PreventionContinue Reading